Sheri L. Holmen
- Genetics top 2%
- Glioma Diagnosis and Treatment 12
- Virus-based gene therapy research 6
- Molecular Biology top 5%
- Melanoma and MAPK Pathways 26
- RNA Interference and Gene Delivery 6
- PI3K/AKT/mTOR signaling in cancer 6
- Wnt/β-catenin signaling in development and cancer 6
- Cancer Research top 5%
- Oncology top 5%
- Immunology top 10%
- Immunotherapy and Immune Responses 7
-
- Cancer Mechanisms and Therapy 11
- Co-authors
- Bart O. WilliamsHoward ColmanAdam L. CohenCassandra R. ZylstraMary BouxseinMatthew W. VanBrocklinMatthew L. WarmanMinrong Ai
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Sheri L. Holmen
60 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Genetics 572
- Molecular Biology 2.1k
- Cancer Research 450
- Oncology 784
- Immunology 401
Countries citing papers authored by Sheri L. Holmen
This map shows the geographic impact of Sheri L. Holmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheri L. Holmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheri L. Holmen more than expected).
Fields of papers citing papers by Sheri L. Holmen
This network shows the impact of papers produced by Sheri L. Holmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheri L. Holmen. The network helps show where Sheri L. Holmen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sheri L. Holmen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 4 | |
| 6 | 2019 | 21 | |
| 7 | 2019 | 44 | |
| 8 | 2019 | 4 | |
| 9 | 2018 | 40 | |
| 10 | 2017 | 72 | |
| 11 | 2017 | 17 | |
| 12 | 2016 | 9 | |
| 13 | 2015 | 105 | |
| 14 | 2013 | 25 | |
| 15 | 2012 | 23 | |
| 16 | 2010 | 29 | |
| 17 | 2009 | 59 | |
| 18 | 2009 | 7 | |
| 19 | 2007 | 31 | |
| 20 | 2007 | 46 |
About Sheri L. Holmen
Sheri L. Holmen is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine, having authored 63 papers that have together received 3.0k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (26 papers), Glioma Diagnosis and Treatment (12 papers), Cancer Mechanisms and Therapy (11 papers), Immunotherapy and Immune Responses (7 papers), Virus-based gene therapy research (6 papers), RNA Interference and Gene Delivery (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Wnt/β-catenin signaling in development and cancer (6 papers). The work is most often cited by research in Genetics (572 citations), Molecular Biology (2.1k citations) and Cancer Research (450 citations). Sheri L. Holmen has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Bart O. Williams, Howard Colman, Adam L. Cohen, Cassandra R. Zylstra, Mary Bouxsein, Matthew W. VanBrocklin, Matthew L. Warman, Minrong Ai, James P. Robinson and Marie–Claude Faugere. Their work appears in journals such as Cancer Research, Oncogene, Pigment Cell & Melanoma Research, Neuro-Oncology and Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.